Oscar Health's Q2 2025: Key Contradictions in Risk Adjustments, Membership Trends, and Market Positioning
Generado por agente de IAAinvest Earnings Call Digest
miércoles, 6 de agosto de 2025, 9:46 pm ET1 min de lectura
OSCR--
Risk adjustment payable as a percentage of revenue, future membership trends, risk adjustment payable as a percentage of premiums, and market stability and competitive positioning are the key contradictions discussed in Oscar Health's latest 2025Q2 earnings call.
Revenue and Membership Growth:
- Oscar HealthOSCR--, Inc. reported total revenue of $2.9 billion for Q2 2025, a 29% increase year-over-year.
- Membership grew by 28% year-over-year, reaching more than 2 million members.
- The growth was driven by strong retention, above-market growth during open enrollment, and continuing SEP member additions.
Medical Loss Ratio (MLR) and Risk Adjustment Payable:
- The second-quarter medical loss ratio (MLR) increased by 12 points year-over-year to 91.1%.
- This increase was primarily due to a $316 million increase to the risk adjustment payable for 2025.
- The rise in MLR was attributed to higher average market morbidity, driven by the entry of consumers into the individual market for Medicaid redeterminations and healthier, low-utilizing consumers leaving the market.
Financial Performance and Guidance:
- Oscar reported a loss from operations of $230 million and an adjusted EBITDA loss of $199 million for Q2 2025.
- The company reaffirmed its updated 2025 guidance, including revenue of $12 billion to $12.2 billion and a loss from operations of $200 million to $300 million.
- The guidance was revised based on better-than-expected retention and higher SEP member additions, amidst a market-wide shift towards higher average market morbidity.
Strategic Initiatives for Market Stability:
- Oscar is implementing a series of strategic steps to address market instability, including submitting 2026 rate filings and partnering with consumer brands to expand its market reach.
- The company is focused on stabilizing the market in 2026 by addressing morbidity pressure and the effects of program integrity efforts through rate increases.
- These initiatives are aimed at ensuring a return to profitability in 2026 and long-term growth.

Revenue and Membership Growth:
- Oscar HealthOSCR--, Inc. reported total revenue of $2.9 billion for Q2 2025, a 29% increase year-over-year.
- Membership grew by 28% year-over-year, reaching more than 2 million members.
- The growth was driven by strong retention, above-market growth during open enrollment, and continuing SEP member additions.
Medical Loss Ratio (MLR) and Risk Adjustment Payable:
- The second-quarter medical loss ratio (MLR) increased by 12 points year-over-year to 91.1%.
- This increase was primarily due to a $316 million increase to the risk adjustment payable for 2025.
- The rise in MLR was attributed to higher average market morbidity, driven by the entry of consumers into the individual market for Medicaid redeterminations and healthier, low-utilizing consumers leaving the market.
Financial Performance and Guidance:
- Oscar reported a loss from operations of $230 million and an adjusted EBITDA loss of $199 million for Q2 2025.
- The company reaffirmed its updated 2025 guidance, including revenue of $12 billion to $12.2 billion and a loss from operations of $200 million to $300 million.
- The guidance was revised based on better-than-expected retention and higher SEP member additions, amidst a market-wide shift towards higher average market morbidity.
Strategic Initiatives for Market Stability:
- Oscar is implementing a series of strategic steps to address market instability, including submitting 2026 rate filings and partnering with consumer brands to expand its market reach.
- The company is focused on stabilizing the market in 2026 by addressing morbidity pressure and the effects of program integrity efforts through rate increases.
- These initiatives are aimed at ensuring a return to profitability in 2026 and long-term growth.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios